Davidson Capital Management Inc. Vertex Pharmaceuticals Inc Transaction History

Davidson Capital Management Inc.

$343 Million
Q3 2024

A detailed history of Davidson Capital Management Inc. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Davidson Capital Management Inc. holds 6,531 shares of VRTX stock, worth $2.94 Million. This represents 0.89% of its overall portfolio holdings.

Number of Shares

6,531

Previous 7,205 9.35%

Holding current value

$2.94 Million

Previous $3.38 Million 10.07%

% of portfolio

0.89%

Previous 1.04%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 25, 2024	SELL	$460.0 - $505.78 $310,040 - $340,895	-674 Reduced 9.35%	6,531 $3.04 Million
Q2 2024 Aug 12, 2024	BUY	$392.81 - $485.53 $543,256 - $671,487	1,383 Added 23.75%	7,205 $3.38 Million
Q1 2024 May 06, 2024	BUY	$407.69 - $446.08 $26,499 - $28,995	65 Added 1.13%	5,822 $2.43 Million
Q4 2023 Feb 08, 2024	BUY	$343.0 - $410.68 $269,598 - $322,794	786 Added 15.81%	5,757 $2.34 Million
Q3 2023 Oct 31, 2023	SELL	$338.18 - $362.46 $7,439 - $7,974	-22 Reduced 0.44%	4,971 $1.73 Million
Q2 2023 Aug 02, 2023	BUY	$314.42 - $351.91 $9,747 - $10,909	31 Added 0.62%	4,993 $1.76 Million
Q1 2023 May 01, 2023	SELL	$283.23 - $323.1 $117,823 - $134,409	-416 Reduced 7.74%	4,962 $1.56 Million
Q4 2022 Feb 07, 2023	SELL	$285.76 - $321.48 $5,429 - $6,108	-19 Reduced 0.35%	5,378 $1.55 Million
Q3 2022 Nov 09, 2022	BUY	$273.83 - $305.53 $54,766 - $61,105	200 Added 3.85%	5,397 $1.56 Million
Q2 2022 Aug 17, 2022	SELL	$234.96 - $292.55 $331,998 - $413,373	-1,413 Reduced 21.38%	5,197 $1.46 Million
Q1 2022 May 17, 2022	BUY	$221.42 - $260.97 $355,157 - $418,595	1,604 Added 32.04%	6,610 $1.73 Million
Q4 2021 Feb 02, 2022	SELL	$177.01 - $223.45 $217,368 - $274,396	-1,228 Reduced 19.7%	5,006 $1.1 Million
Q3 2021 Nov 10, 2021	BUY	$181.39 - $202.99 $46,435 - $51,965	256 Added 4.28%	6,234 $1.13 Million
Q2 2021 Aug 10, 2021	BUY	$187.49 - $221.1 $158,991 - $187,492	848 Added 16.53%	5,978 $1.21 Million
Q1 2021 May 10, 2021	BUY	$207.02 - $241.31 $401,411 - $467,900	1,939 Added 60.76%	5,130 $1.1 Million
Q4 2020 Feb 16, 2021	BUY	$207.01 - $276.09 $24,220 - $32,302	117 Added 3.81%	3,191 $754,000
Q3 2020 Nov 12, 2020	BUY	$255.65 - $303.1 $15,594 - $18,489	61 Added 2.02%	3,074 $836,000
Q2 2020 Aug 13, 2020	BUY	$225.48 - $295.8 $31,792 - $41,707	141 Added 4.91%	3,013 $875,000
Q1 2020 May 14, 2020	BUY	$199.77 - $247.81 $573,739 - $711,710	2,872 New	2,872 $683,000

Others Institutions Holding VRTX

# of Institutions

1,723

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Davidson Capital Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Davidson Capital Management Inc. with notifications on news.

Account

Davidson Capital Management Inc. Vertex Pharmaceuticals Inc Transaction History